Apeiron Capital Investment Quick Ratio (APN) starting from the first quarter 2023 to first quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Apeiron Capital Investment Corp   (NYSE: APN)

Apeiron Capital Investment 's Quick Ratio

APN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2023, Quick Ratio deteriorated to 0.31 below Apeiron Capital Investment 's average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 193 other companies have achieved higher Quick Ratio than Apeiron Capital Investment in first quarter 2023. While Quick Ratio total ranking in the first quarter 2023 has deteriorated compared to the prior quarter from 3551 to 4148.

Explain Quick Ratio?
How much Cash & cash equivalents APN´s has?
What are APN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APN Quick Ratio (Mar 31 2023)
Q1		 (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1
Y / Y Current Liabilities Change 651.91 % 1017.1 % 247.88 % - -
Y / Y Cash & cash equivalent Change -2.07 % 45.61 % 2131.17 % - -
Quick Ratio MRQ 0.31 0.51 0.7 1.33 2.42
APN's Total Ranking # 4148 # 3551 # 2358 # 2420 # 1752
Seq. Current Liabilities Change -6.15 % 167.08 % 89.91 % 57.95 % 39.44 %
Seq. Cash & cash equivalent Change -42.34 % 96.2 % -0.08 % -13.38 % -14.26 %



Quick Ratio first quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 194
Healthcare Sector # 1114
Overall Market # 4148


Quick Ratio Statistics
High Average Low
3.93 1.33 0.11
(Dec 31 2021)   (Sep 30 2021)




Financial Statements
Apeiron Capital Investment 's Current Liabilities $ 2 Millions Visit APN's Balance sheet
Apeiron Capital Investment 's Cash & cash equivalent $ 1 Millions Visit APN's Balance sheet
Source of APN's Sales Visit APN's Sales by Geography


Cumulative Apeiron Capital Investment 's Quick Ratio

APN's Quick Ratio for the trailling 12 Months

APN Quick Ratio

 (Mar 31 2023)
12 Months		 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 679.62 % 760.47 % 630.2 % - -
Y / Y Cash & cash equivalent TTM Growth 99.96 % 267.62 % 9948.07 % - -
Quick Ratio TTM 0.53 0.79 1.5 1.79 2.07
Total Ranking TTM # 5928 # 5976 # 2902 # 5974 # 5560
Seq. Current Liabilities TTM Growth 47.97 % 115.85 % 51.39 % 61.23 % 63.31 %
Seq. Cash & cash equivalent TTM Growth -0.47 % 13.65 % 26.92 % 39.28 % 82.98 %

Quick ratio ranking by company, industry and sector >> Back to APN Financial Strength Comparisons >> Go to Compare APN Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2023 to $2.00 millions, cumulative Quick Ratio decreased to 0.53 above the APN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 194 other companies have achieved higher Quick Ratio than Apeiron Capital Investment . While Quick Ratio overall ranking has improved so far to 5928, from total ranking during the twelve months ending fourth quarter 2022 at 5976.

Explain Quick Ratio?
How much Cash & cash equivalents APN´s has?
What are APN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 195
Healthcare Sector # 1242
Within the Market # 5928


trailing twelve months Quick Ratio Statistics
High Average Low
0.53 0.26 0.14
(Mar 31 2023)   (Mar 31 2022)




Companies with similar Quick Ratio in the quarter ending Mar 31 2023, within Biotechnology & Pharmaceuticals Industry Quick RatioMar 31 2023 MRQ Cash & cash equivalentMar 31 2023 MRQ Current Liabilities
Fate Therapeutics Inc   0.86 $ 42.020  Millions$ 48.651  Millions
Meiragtx Holdings Plc  0.85 $ 68.784  Millions$ 81.104  Millions
Valneva Se  0.79 $ 141.210  Millions$ 177.927  Millions
Evaxion A  0.75 $ 6.398  Millions$ 8.489  Millions
Biogen Inc   0.71 $ 2,143.100  Millions$ 3,014.900  Millions
Pluri Inc   0.68 $ 3.677  Millions$ 5.377  Millions
Armata Pharmaceuticals Inc   0.66 $ 25.106  Millions$ 38.311  Millions
Mesoblast Limited  0.65 $ 71.318  Millions$ 109.210  Millions
Eiger Biopharmaceuticals Inc   0.64 $ 15.181  Millions$ 23.564  Millions
Champions Oncology Inc   0.47 $ 10.118  Millions$ 21.733  Millions
Titan Pharmaceuticals Inc   0.46 $ 1.136  Millions$ 2.447  Millions
Elutia Inc   0.41 $ 11.789  Millions$ 29.059  Millions
Zeo Scientifix Inc   0.35 $ 1.161  Millions$ 3.283  Millions
Novavax inc   0.33 $ 624.950  Millions$ 1,918.858  Millions
Apeiron Capital Investment Corp   0.31 $ 0.631  Millions$ 2.005  Millions
Sorrento Therapeutics Inc   0.30 $ 50.317  Millions$ 165.632  Millions
Xtant Medical Holdings Inc   0.30 $ 5.176  Millions$ 17.276  Millions
Eloxx Pharmaceuticals Inc   0.26 $ 4.904  Millions$ 18.793  Millions
Ladrx Corporation  0.26 $ 0.606  Millions$ 2.348  Millions
Brainstorm Cell Therapeutics inc   0.21 $ 2.227  Millions$ 10.422  Millions
Galaxy Enterprises Inc   0.21 $ 1,544.000  Millions$ 7,504.000  Millions
Cyclo Therapeutics Inc   0.20 $ 0.915  Millions$ 4.483  Millions
Immunitybio inc   0.16 $ 91.268  Millions$ 564.945  Millions
Aceragen Inc   0.12 $ 2.118  Millions$ 17.863  Millions
Enzo Biochem Inc  0.10 $ 2.632  Millions$ 25.289  Millions
Kiromic Biopharma Inc   0.10 $ 2.054  Millions$ 19.860  Millions
Atlantic Coastal Acquisition Corp Ii  0.10 $ 0.295  Millions$ 3.083  Millions
Gilead Sciences Inc   0.09 $ 936.000  Millions$ 10,528.000  Millions
Scilex Holding Company  0.08 $ 5.069  Millions$ 64.602  Millions
Tevogen Bio Holdings Inc   0.08 $ 0.052  Millions$ 0.667  Millions

Date modified: 2026-09-26T07:41:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.